Managed Care Analytics

To meet the increasing market complexities, pharma account managers seek solutions to effectively size and deploy account teams and measure contract performance across many overlapping market fragments. 

Axtria’s managed markets solutions provide ‘where to play’ and ‘how to win’ strategies in a multi-stakeholder model. HEOR-based models account for health value beyond efficacy to ensure portfolio-based innovation and best-in-class outcomes.

Key Offerings


Managed Markets and
HEOR Analytics

Unveil market complexities with Axtria’s deep domain and strategy consulting expertise in managed markets, and hands-on experience with traditional and emerging datasets in this space.


Managed Care

Examine the impact of ‘share of practice’ changes in one category on others. Data from multiple feeds come together into the modelling environment, to help map the managed care landscape for a brand.


Co-pay Elasticity

Drive your product market share by assessing the impact of self and competitor copay by individual plan category, with the help of Axtria’s copay elasticity models.



Optimize deal performance with a comprehensive evaluation of all the factors that influence a deal. Axtria’s Deal Assessment Framework provides predictive capability for effective negotiations.


Managed Care
Influence Analysis

Optimize resource allocation by assessing managed care influence along with other local drivers. With geography profiling for each key driver, the analysis can be performed at a sub national level (varied geography levels)



Focus on high value payer segments with Axtria’s segmentation models that help guide ‘where to play’ and ‘how to win’ decisions. Key outputs include actionable segments, opportunities, and action plans.

Customer Success Stories

Explore How Axtria Helps Life Sciences Businesses Achieve Commercial Success.

Analytics Center of Excellence
Data & Analytics Center Of Excellence (CoE) For A Global Pharma

Life sciences organizations are struggling with several factors, including fragmented analytics teams, siloed decision making, limited thought leadership, and inflexible operating ...

Strategic Course Correction For A Blockbuster Oncology Drug

A top pharma company that had done well to grow their oncology drug to a blockbuster status was struggling with understanding and achieving its full potential. Axtria provided str ...

sales analytics
Sales Force Restructuring Strategy For A New Oncology Indication Launch In The US

With the rise of specialty pharma, the interactions between sales reps and healthcare stakeholders are becoming more profound, more productive, and much more scientific. ...

Start typing and press Enter to search